AzTrials
AzTrials

Breast Cancer ScreeningNCT07541105

Cancer Awareness Among Syrian Migrants

A study testing PMT-Based Cancer Screening Educational Intervention and PMT-Based Cancer Screening Education Program in people with Breast Cancer Screening and Cervical Cancer Screening, run by Toros University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to develop and evaluate a theory-based educational intervention to improve cancer screening participation among Syrian migrants in Turkey. The study will also develop a Cancer Protection Motivation Scale (CPMS) to measure individuals' motivation toward cancer screening. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
PMT-Based Cancer Screening Educational Intervention and PMT-Based Cancer Screening Education Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
No sites listed yet
Study dates
9 Mar 2027to 9 Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • over 18 years of age
  • hold Syrian citizenship
  • be registered with the Migrant Health Center in Mersin province
  • have proficiency in Turkish or Arabic
  • voluntarily agree to participate

Who cannot join

  • if they hold Turkish citizenship
  • have a diagnosed psychiatric disorder
  • have been diagnosed with cancer
  • wish to withdraw from the study

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Neslihan ÖZCANARSLAN, Phd contact

+905336671604

neslihan.ozcanarslan@toros.edu.tr

About this study

Official title: A Theory-Driven Educational Intervention to Enhance Cancer Screening Uptake Among Syrian Migrants in Turkey: A Study Protocol

This study aims to develop and evaluate a theory-based educational intervention to improve cancer screening participation among Syrian migrants in Turkey. The study will also develop a Cancer Protection Motivation Scale (CPMS) to measure individuals' motivation toward cancer screening. Using a mixed-methods design, the study will explore barriers, beliefs, and behaviors related to breast, cervical, and colorectal cancer screening. The effectiveness of the intervention will be assessed using a pretest-posttest design. The findings are expected to support culturally appropriate strategies to improve cancer screening uptake among migrant populations.

Read the detailed description

Syrian migrants face difficulties accessing cancer screening services due to limited healthcare access, language and cultural barriers, and lack of knowledge about cancer screening. However, there is a lack of practical guidance on how public health initiatives can effectively engage with priority populations, particularly migrants. This study aims to present a protocol for developing a Protection Motivation Theory (PMT)-based educational intervention and the Cancer Protection Motivation Scale, informed by an examination of migrants' and healthcare professionals' perspectives on cancer screening. A mixed-methods study protocol has been developed to create a Protection Motivation Theory (PMT)-based educational intervention and the Cancer Protection Motivation Scale. The study will engage migrants and healthcare professionals to explore knowledge, attitudes, behaviors, and barriers related to breast, cervical, and colorectal cancer screening. In the qualitative phase, interviews will be conducted with 30 migrants and healthcare professionals, while in the methodological phase, data from 300 migrants will be used to develop and validate the scale and educational intervention. In the experimental phase, the effectiveness of the intervention will be tested with 30 participants. The study is expected to yield a valid and reliable Cancer Protection Motivation Scale and a culturally sensitive, theory-driven educational intervention. These tools will provide guidance for improving cancer awareness and screening behaviors among migrants, addressing barriers related to access, language, culture, and knowledge.

Being tested
PMT-Based Cancer Screening Educational Intervention, PMT-Based Cancer Screening Education Program
Keywords
Breast cancer, Colon cancer, Cervical cancer, Protection motivation, Reduced inequalities
Medical subject headings
Breast Neoplasms, Colonic Neoplasms, Uterine Cervical Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PMT-Based Cancer Screening Educational InterventionOther

    This intervention is a structured educational program developed based on Protection Motivation Theory (PMT). It aims to improve cancer screening behaviors among Syrian migrants through culturally adapted educational sessions focusing on breast, cervical, and colorectal cancer screening. The intervention targets key components of PMT, including threat appraisal (perceived severity, perceived vulnerability, and rewards) and coping appraisal (self-efficacy, response efficacy, and perceived costs). Educational content is designed to increase awareness, enhance motivation, and reduce perceived barriers. Participants will receive the training through interactive sessions. The effectiveness of the intervention will be evaluated using pretest and posttest assessments with the Cancer Protection Motivation Scale (CPMS).

  • PMT-Based Cancer Screening Education ProgramBehavioural

    Also called PMT Education Program, Cancer Screening Education Intervention

    This behavioral intervention is a structured education program based on Protection Motivation Theory (PMT), designed to improve cancer screening behaviors among Syrian migrants. The program targets key PMT constructs, including perceived severity, perceived vulnerability, response efficacy, self-efficacy, and perceived barriers. It includes culturally adapted, interactive educational sessions focusing on breast, cervical, and colorectal cancer screening. The intervention aims to increase knowledge, enhance motivation, and reduce perceived barriers to screening participation. Effectiveness will be evaluated using pre- and post-intervention assessments with the Cancer Protection Motivation Scale (CPMS).

Study groups in NCT07541105
Study groupRoleWhat they receive
The group receiving the PMT-based cancer screening educational intervention.ExperimentalA Protection Motivation Theory (PMT)-based educational program focusing on breast, cervical, and colorectal cancer screening will be delivered to participants. Pretest and posttest assessments will be conducted using the Cancer Protection Motivation Scale (CPMS) to evaluate changes in motivation and screening-related behaviors.
Receives: Other: PMT-Based Cancer Screening Educational Intervention; Behavioral: PMT-Based Cancer Screening Education Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cancer Protection Motivation Scale (CPMS)

    Cancer protection motivation will be assessed using the Cancer Protection Motivation Scale (CPMS), a researcher-developed multidimensional instrument based on Protection Motivation Theory. The scale measures threat appraisal (perceived severity, vulnerability, and rewards), coping appraisal (response efficacy and response cost), and self-efficacy. The CPMS is planned to consist of 24 items rated on a 5-point Likert scale ranging from 1 = strongly disagree to 5 = strongly agree. The total score ranges from 24 to 120, with higher scores indicating greater motivation. Content validity will be evaluated using the Content Validity Index (CVI) based on the opinions of approximately 20 experts. Following language validation, a pilot study will be conducted with 20 participants, after which the scale will be administered to 300 individuals. The CPMS will be used as a pretest and posttest to evaluate effectiveness.

    Measured: Baseline and 1 month after the intervention

Secondary outcomes (1)
  1. Knowledge of Cancer and Screening (Structured Questionnaire Score)

    Participants' knowledge regarding breast, cervical, and colorectal cancers and related screening programs will be assessed using a researcher-developed structured questionnaire. The questionnaire will include items on cancer risk factors, symptoms, and screening recommendations. It will be administered before the intervention (pretest) and after the educational program (posttest). Higher scores will indicate greater knowledge.

    Measured: Baseline and 1 month after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Apr 2026
  2. Study start9 Mar 2027 (estimated)
  3. Primary completion9 Jul 2027 (estimated)
  4. Study completion9 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
This is a single-group pretest-posttest study. All participants will receive the same educational intervention; therefore, masking is not applicable.
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07541105
Sponsor's protocol ID
22.06.2022/130
Status last verified
Oct 2026
First submitted
11 Apr 2026
Last updated
15 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing PMT-Based Cancer Screening Educational Intervention and PMT-Based Cancer Screening Education Program in people with Breast Cancer Screening and Cervical Cancer Screening, run by Toros University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 15 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Neslihan ÖZCANARSLAN, Phd (+905336671604, neslihan.ozcanarslan@toros.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cancer Protection Motivation Scale (CPMS) (time frame: Baseline and 1 month after the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in